Viewing Study NCT00946556

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:19 PM
Ignite Modification Date: 2026-02-24 @ 1:15 AM
Study NCT ID: NCT00946556
Status: COMPLETED
Last Update Posted: 2012-03-22
First Post: 2009-07-23
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Examining the Ability of Herpes Simplex Virus Type 2 (HSV2) Therapy to Reduce HIV Target Cell Numbers in the Cervix
Sponsor: University of Toronto
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Herpes Simplex Type Two Infection View
None HIV Infections View
Keywords:

Keywords

Keyword Brief Keyword Text View
None herpes simplex virus type 2 View
None HIV View
None genital immunology View
None CD4+ T cell View
None valacyclovir View
None HIV seronegativity View